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Abstract
Purpose: The human chromosome 19q13.11 deletion syndrome is associated with a variable
phenotype that includes aplasia cutis congenita (ACC) and ectrodactyly as specific features. UBA2
(ubiquitin-like modifier-activating enzyme 2) lies adjacent to the minimal deletion overlap region.
We aim to define the UBA2-related phenotypic spectrum in humans and zebrafish due to sequence
variants and to establish the mechanism of disease.
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Methods: Exome Sequencing was used to detect UBA2 sequence variants in 16 subjects in 7
unrelated families. uba2 loss-of-function was modeled in zebrafish. Effects of human missense
variants were assessed in zebrafish rescue experiments.
Results: 7 human UBA2 loss-of-function and missense sequence variants were detected. UBA2
phenotypes included ACC, ectrodactyly, neurodevelopmental abnormalities, ectodermal, skeletal,
craniofacial, cardiac, renal, and genital anomalies. uba2 was expressed in zebrafish eye, brain, and
pectoral fins; uba2-null fish showed deficient growth, microcephaly, microphthalmia, mandibular
hypoplasia, and abnormal fins. uba2-mRNAs with human missense variants failed to rescue
nullizygous zebrafish phenotypes.
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Conclusion: UBA2 variants cause a recognizable syndrome with a wide phenotypic spectrum.
Our data suggest that loss of UBA2 function underlies the human UBA2 monogenic disorder and
highlights the importance of SUMOylation in the development of affected tissues.

Introduction

Author Manuscript

Features of the chromosome 19q13.11 deletion syndrome include early growth deficiencies,
developmental delay, distinctive facial features, aplasia cutis congenita (ACC), hip dysplasia,
digital and limb anomalies including ectrodactyly, and other malformations1–8. Deletions
range in size from 1.37–11 Mb with a minimum overlapping region (MOR) of 324 kb,
without clear genotype-phenotype correlation3,4,6. UBA2 lies adjacent to the MOR and
has been proposed to underlie key aspects of the deletion phenotype including ACC and
ectrodactyly1,2,3,5,6. Limited patient data and lack of an animal model have prevented
establishing UBA2 as the causative gene.

UBA2 plays a key role in the posttranslational modification of protein (SUMOylation) by
the addition of SUMO1 (small ubiquitin-like modifier) protein. UBA2 forms a heterodimer
with SAE1 (SUMO-Activating Enzyme Subunit 1) and binds with SUMO1 in an ATP
dependent manner9–11. Unlike ubiquitination, SUMOylation does not only target proteins
for degradation, but is involved in cell cycle regulation, subcellular trafficking, signal
transduction, stress responses and chromatin structure dynamics. SUMOylation alters
protein kinases and transcription factors to maintain transcriptional regulation of tissue
specific gene expression12.
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In this study, we report 16 additional individuals from seven unrelated families with de
novo and familial UBA2 sequence variants who have highly variable but overlapping clinical
presentations. In silico modeling and a zebrafish uba2 nullizygous phenotype provides
further functional evidence for the pathogenicity of UBA2 as the key gene underlying the
chromosome19q13.11 microdeletion syndrome.

Material and methods
Subject enrollment and clinical evaluations
Each described patient was evaluated by a clinical geneticist. Written informed consent was
obtained for exome sequencing either on a clinical or research basis. A written informed
consent was also obtained from subjects to publish their photos. Genomic DNA was
extracted from whole blood from affected probands and their biological parents for exome
sequencing. See supplement for details.
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Zebrafish modeling of the phenotypic effects of uba2 variants
All animal experiments were conducted in accordance with recommendations of the Guide
for the Care and Use of Laboratory animals of the National Institutes of Health (Protocol #
NEI-679). Adult AB (Tubingen) and ABTL (Tubingen long fin) zebrafish strains were raised
and maintained according to standard protocols as described13.
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Whole mount in situ hybridization
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Wild type (WT) zebrafish embryos at different developmental stages (5 somite, 24, 35,
48, 72hpf (hours post fertilization), 5 and 7 dpf (days post fertilization) were fixed in
preparation for performing in situ hybridization. See supplement method section for details.
CRISPR/Cas9 uba2 knock out line generation
CRISPR/Cas9 method was used to generate uba2 knockout zebrafish lines. See supplement
method section for details.
mRNA rescue
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To evaluate the impact of human UBA2 variants on encoded protein products, we utilized
uba2-mutant fish to perform rescue studies with capped full-length human WT and missense
alleles in mRNA transcribed with the T7 mMESSAGE mMACHINE kit (Ambion).
Please see supplement for other methodology details.

Results
Clinical studies
The cohort was gathered through GeneDx, a clinical molecular laboratory, and
GeneMatcher. Investigators independently ascertained families with related phenotypes and
rare candidate variants. Table 1 and the supplement contain additional clinical details.
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Family 1: Family 1 (Fig. 1 and 2) is comprised of an affected mother and her four
offspring. Two children have ACC. By report, the maternal grandmother and great
grandmother also have histories of ACC. Other ectodermal changes are variable including
thin scalp hair, xerosis and dental anomalies. The index case (IV-4, Fig. 1a and 1b) has
unilateral ectrodactyly of hand. All of the other affected examined individuals have more
subtle digital variations including camptodactyly, syndactyly, clinodactyly and diminished
distal flexion creases of the fingers. All affected individuals share a high anterior hairline
and mild frontal bossing, and several, including the proband (IV-4), have slightly down
slanted palpebral fissures. All have had highly variable neurodevelopmental problems,
ranging from hypotonia to autism spectrum disorder in two of the brothers. Hypotonia
generally persisted throughout childhood. Affected individuals had early growth deficiencies
that improved with age. See supplement for other details. All affected individuals studied are
heterozygous for a UBA2 frameshift variant: c.816_817delAT, p.Trp273Alafs*13.
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Family 2: This family consists of three affected brothers (Fig. 1b: II-1, II-2, II-3); neither
parent is affected. Parentage was genetically confirmed prior to exome sequencing. All
affected individuals have histories of hypotonia through childhood that impeded motor
development and even feeding ability in early infancy, and sensory integration problems,
but normal cognitive abilities. Neither ACC nor other ectodermal changes are noted, but
the youngest brother (II-3) has unilateral cleft hand and polydactyly. More subtle foot,
toe, and other minor digital anomalies vary among the three affected males. All three also
have histories of cryptorchidism and/or hypospadias. Each is heterozygous for a “de novo”
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frameshift UBA2 variant, c.1376_1377insT, p.Thr460Aspfs*24, not detected in blood of
either parent with either NextGen (130X coverage at 10X depth) or Sanger sequencing.
Family 3: Clinical details about part of this family were reported previously14 but are
now updated and expanded along with results of exome analysis. The male proband (II-2,
Fig. 1a and 1b) has a single area of ACC, supernumerary nipple, cryptorchidism, early
developmental delay, astigmatism, learning disability, depression, bipolar disorder, and
social phobia. His mother (I-2) has multiple areas of healed ACC, supernumerary nipples,
small head circumference, and asymmetric kidneys with reduced renal function. Neither
have documented hand or foot anomalies. They are both heterozygous for a nonsense variant
in UBA2: c.364C>T, p.Arg122*. Two other affected individuals (II-1 and III-1) have similar
facial features, ACC, and supernumerary nipples and were each confirmed to harbor the
familial UBA2 variant.
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Family 4: The female proband (II-1, Fig. 1b), 21 years old at examination, has a history of
delayed motor skills and attention deficit disorder. Height, weight, and head circumference
are all currently less than the third percentile; she also had early growth deficiency, delayed
dentition and bone age. Features include ACC, thin scalp hair, clinodactyly, and overlapping
toes. See Table 1 and supplement for additional endocrine, renal, and ophthalmologic
concerns. She is heterozygous for a de novo missense variant in UBA2, c.167A>C:
p.Asn56Thr.
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Family 5: The female proband (Fig. 1b, II-1), 4 years and 9-months-old at exam, has
developmental delay, absent speech, hemangiomas, ACC, and seizures. She has relative
macrocephaly, epicanthal folds, anteriorly placed anus, and pes planus. She carries a de novo
missense UBA2 variant: c.1447G>A, p.Glu483Lys.
Family 6: The proband is a male toddler (Fig. 1a and 1b, II-1) with cryptorchidism,
bilateral inguinal hernias, and multiple limb deformities including bilateral ectrodactyly
of the feet, complete 2–3 finger syndactyly, clinodactyly and camptodactyly. He has lownormal growth and normal developmental milestones. Facial features include hypertelorism,
bilateral epicanthal folds and pseudostrabismus. He does not have ACC or other ectodermal
abnormalities. He is heterozygous for a de novo UBA2 nonsense variant c.800T>A,
p.Leu267*.
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Family 7: The proband (Fig. 1b, II-1) is a 3 year 11-month-old Caribbean male born at 35
weeks gestational age. At two weeks, height and weight (corrected for prematurity) were
normal, but head circumference measured at the 2nd centile. He had global developmental
delay and four limb ectrodactyly, tall and prominent forehead, deep-set eyes, broad nasal
root, left preauricular tag, narrow palate, and a vertical cleft chin. Pre-surgery, he had left
2–3 finger syndactyly with a nodule adjacent to the medial aspect of the PIP joint of the 4th
finger. The right 3rd digit is missing; other digits are relatively normal. On the left foot, 2
malformed digits are divided by a deep central cleft; the right foot also has a deep central
cleft with 3 malformed digits, and 4–5 toe syndactyly. He does not have ACC but has large
areas of faint hypopigmentation over his torso and limbs. He is heterozygous for a de novo
missense variant in UBA2: c.364C>G, p.Arg122Gly.
Genet Med. Author manuscript; available in PMC 2021 November 26.
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None of the detected UBA2 variants was found in the GnomAD database15. Results of
in silico predictor analyses for missense variants and variant classification is provided in
Supplementary Tables 1 and 2. All would be classified as pathogenic or likely pathogenic
using American College of Medical Genetics and Genomics (ACMG)/Association for
Molecular Pathology (AMP) guidelines (classification criteria)16 in Supplemental Table 2.
Modeling effects of missense variants on UBA2 function
UBA2 in complex with SAE1 plays a key role in the SUMOylation pathway. Observed
human UBA2 variants are distributed across the gene (Fig. 2a and b). All truncating variants
are expected to undergo nonsense-mediated decay based on their position within the mRNA.
Missense variants occur at residues that are strongly conserved across vertebrates (Fig.
2c). Given the similarities in phenotypes between individuals with truncating and missense
alleles, we hypothesized that missense alleles also lead to loss-of-function.
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To understand how missense alleles might disrupt UBA2 function, molecular modeling
using published crystal structures17 and simulated substitutions were performed for each
detected human missense variant. In the UBA2 protein, p.Gly2418 is directly involved in
ATP binding; its substitution with valine results in altered protein conformation and is
predicted to result in loss of ATP binding and ectopic interactions with nearby residues (Fig.
2d)17. Similarly, asparagine replacement with threonine at position 56 putatively abolishes
ATP-dependent activation. The p.Arg122Gly substitution is predicted to result in loss of
interaction with ATP. Human UBA2 protein interacts with a conjugating enzyme called
UBC9 (amino acids 6–38) via amino acid residues 478–509, which include Glutamate
483. UBA2 forms a hydrophobic bond with Leu6, Met36 and Leu38 of UBC9; replacing
Glutamate 483 with Lysine is predicted to disrupt UBA2-UBC9 binding. In summary,
missense alleles observed in patients with UBA2-associated syndrome are observed to occur
at functionally critical residues and potentially disrupt ATP-binding, protein folding, or
protein-protein interactions.
Zebrafish uba2 expression in affected tissues
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By whole mount in situ hybridization, uba2 transcript was detected on the dorsoventral axis
of 5-somite stage embryos (Fig. S1a and b). At later stages, uba2 is expressed in developing
brain, eye, craniofacial structures, and fins. At 24 hpf, uba2 expression was restricted to the
head region, including the eye and nervous system (Fig. S1c). At 35 hpf, prominent signal
was observed in pectoral fins (arrows, Fig. S1d). At all other examined stages (48 and 72
hpf, 5 and 7 dpf), uba2 mRNA signal localized to the head region, specifically brain, neural
retina, and lens (Fig. S1e–h). Therefore, zebrafish uba2 is expressed in some structures that
are analogous to those affected in humans harboring deleterious UBA2 variants.
Variable expressivity observed with uba2 loss-of-function

uba2 knockout zebrafish lines were generated by CRISPR/Cas9-targeted deletion. The
phenotype of homozygous fish was notable for failure to inflate swim bladders. At 5–
8 dpf, we observed severe gross morphological defects in uba2−/− zebrafish (Fig. 3)
including small eyes, hydrocephalus and craniofacial edema, ventrally-curved body axis,
and uninflated swim bladder. Faint heartbeat and severe pericardial edema were observed in
Genet Med. Author manuscript; available in PMC 2021 November 26.
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41% of embryos (Fig. 3a and b). Edema became generalized at 8 dpf when most lethality
was noted. To further examine the effect of uba2 on zebrafish development, we calculated
the survival rate of uba2−/− zebrafish which was significantly lower than control (WT) and
heterozygous fish. uba2−/− zebrafish showed a mortality rate of approximately 50% at 8 dpf;
however, 100% of mutant fish were dead by day 12 (Fig. 3d).
Nullizygous fish exhibited a wide phenotypic range. We observed a pair of normal extended
pectoral fins in WT zebrafish versus uba2−/− fish, where pectoral fins were found to be
short and upright-oriented (Fig. 3a) confirming uba2 function in fish extremity development.
WT zebrafish had thin lines originating from base to fin tips showing normal actinotrichia.
In contrast, uba2−/− fish displayed collapsed (Fig. 3b, middle image) and irregular fin fold
edges (Fig. 3b, last image).
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To better characterize variable expression and the relationship between the zebrafish
knockout and the human disorders, we quantified craniofacial (F), brain (B), pectoral fin
(PF), tail fin (TF) and swim bladder (SB) defects. Defects at later stages of development
were studied in uba2−/− fish bred from the same parent at 8 dpf, when approximately half
the fish survive (n=32; Fig. 3c). Tissue-level malformations were observed in craniofacial
structures (9.38%), brain size (90.6%), tail fin (25%), pectoral fin (100%) and swim bladder
(93.75%) (Fig. 3c and as described below). Thus, across individual fish with similar genetic
backgrounds, total uba2 function loss recapitulates some tissue-level phenotypes and the
variable expression observed in human UBA2-related phenotypes.
Neuronal reduction in uba2 zebrafish
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Tissue-level analysis was performed in zebrafish to elucidate abnormalities resulting from
uba2 loss-of-function. First, we conducted immunohistochemistry studies on 8 dpf zebrafish
cryosections through eye and brain. Compared to WT controls, uba2-null fish showed small
heads, reduced midbrain size, low nuclei cell count with high accumulation of actin signal
(orange, Fig. S2), implying a decreased proportion of gray to white matter. In addition,
uba2−/− fish had smaller eyes, reduced retinal thickness, retinal laminations, and lens defects
(see supplement).
Skeletal and extremity phenotypes in the uba2 zebrafish model
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To investigate the impact of uba2 on zebrafish skeletal development, we stained uba2
WT (+/+), heterozygous (+/−) and homozygous (−/−) fish with alcian blue dye at 5
dpf. In both uba2 WT (Fig. 4a) and heterozygous zebrafish (data not shown), alcian
staining demonstrated a normal pattern of cartilage element development including typical
ceratohyoid, Meckel’s cartilage, ceratobranchials arches and pectoral fin cartilage. However,
complete loss of uba2 in homozygous fish resulted in abnormal craniofacial development.
In addition to jaw malformations, other craniofacial malformations included malformed
and hypoplastic ventral and dorsal cartilage structures with lack of basihyal and hypohyal
development. We also noted an apparently abnormal fusion of Meckel’s cartilage with
the palatoquadrate, resulting in a small, narrow mandible (Fig. 4b). Moreover, Meckel’s
cartilage was flattened at the midline fusion point with completely absent ceratohyal
cartilage and ceratobranchials arches, the equivalent of micrognathia in these fish.

Genet Med. Author manuscript; available in PMC 2021 November 26.
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To explore whether uba2 mutation causes skeletal phenotypes in adult fish, we performed
micro-computed tomography (CT) comparing WT (n=3) and uba2+/− (n=3) fish, as
nullizygous fish did not survive to this stage. We noted abnormal, wavy ribs and dysmorphic
fin girdles in uba2+/− fish (Fig. S3).
In teleosts, finfolds are typically made of type II collagen matrix structures called
actinotrichia that line the epidermis. Brightfield microscopy of uba2−/− fish revealed
structural defects in median fins (Fig. 3b). To examine the effect of uba2 truncation on
zebrafish median fin structure development, we stained uba2 zebrafish (+/+, +/− and −/−)
larvae with type II collagen (Col2a) and Phalloidin (F-actin) antibodies to label actinotrichia
(Fig. 4c).
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Actinotrichia fibrils initiate fin development and become the future fin connective tissue.
At 5 dpf, both WT (Fig. 4c, top panel) and heterozygous (data not shown) larvae
develop median fins showed normally arrayed Col2a-labeled actinotrichia fibers; however,
we observed non-rigid, non-parallel and bent actinotrichia in uba2−/− (Fig. 4c, arrows)
fish. Phalloidin staining in uba2−/− fish revealed disorganized and disrupted organization,
corresponding to areas of this abnormal collagen pattern (Fig. 4c).
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Further investigating these extremity defects at a cellular level, we performed ultrastructural
analysis of the uba2 zebrafish body wall near the median finfold at 5 dpf. Detailed
examination by TEM revealed a typical dynamically-assembled dense striated pattern
of actinotrichia in WT fish (Fig. S4). Similarly, in WT fish we observed a normal
and organized distribution of skeletal muscles with normal nuclei and mitochondria.
However, in uba2−/− zebrafish, we observed disorganized (or incompletely developed) and
scattered actinotrichia with abnormal epidermal cells (arrow). The skeletal muscle layer
in homozygous fish was also observed to be discontinuous or atrophic with degenerated
nuclei and mitochondria. Therefore, absent uba2 impacts connective and epithelial tissue and
skeletal muscle and causes extremity malformations in developing fish.
Conserved function of UBA2 candidate variants in zebrafish
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To further confirm the specificity of the uba2 knockout phenotype, we attempted phenotypic
rescue of developmental fish malformations by injecting human UBA2 mRNA. Injected
fish were grouped into three phenotypic classes and genotyped at 5 dpf, and the uba2−/−
subset was analyzed. Embryos were classified as Class I (grossly normal body structure),
Class II (decreased head size, absent swim bladder), and Class III (small head and body,
generalized edema) (Fig. 4d). As compared to H2O-injected controls, injecting human WT
UBA2 mRNA grossly rescued phenotypes in a significant number of fish. The proportion
of Class I fish increased from 5% to 33%, and the proportion of Class III fish decreased
from 47% to 6% (p<0.0001) (Fig. 4e). Even though WT-UBA2 mRNA injection rescued
gross phenotypes, most uba2−/− zebrafish still did not show inflated swim bladder (data not
shown), suggesting that early uba2 deficiency permanently impacts zebrafish physiology
despite substitution with human mRNA.
Human mRNAs encoding p.Gly24Val, p.Arg122Gly and p.Glu483Lys all failed to rescue the
uba2−/− phenotypes in contrast to WT mRNA. The p.Asn56Thr substitution demonstrated
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statistically similar rescue to control mRNA; however, there were more Class III fish (23%
vs 6%) and fewer Class I fish (18% vs 33%) following p.Asn56Thr injection, indicating
possible partial loss-of-function for this missense substitution (Fig. 4e). Because the mRNAs
containing the missense variants failed to rescue uba2-null phenotypes to a similar level
as did WT UBA2 mRNA, we conclude that the most likely mechanism of disease is
loss-of-function.

Discussion
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In this study, we describe a cohort of patients harboring deleterious variants in the UBA2
gene. They show highly variable inter- and intra-familial expression of dermatologic,
skeletal, extremity, neurologic, cardiac, and renal features, similar to those of the
chromosome 19q13.11 microdeletion syndrome1–8. These observations further support
UBA2 as the critical gene in the microdeletion syndrome and suggest its essential role
in early human growth and development. There are only a few other reports of intragenic
UBA2 variants (summarized in Table 1). Marble et al.18 reported a de novo UBA2 missense
variant (c.71G>T, p.Gly24Val) in a 2.5-year-old female with ACC, thin hair, tall forehead,
Duane anomaly, hip dysplasia, clinodactyly, and poor weight gain. Wang et al.18 reported
an inherited UBA2 frameshift variant [c.327delT, p.Phe109Leufs*3] in a young boy and his
mother. The mother had ACC but was otherwise healthy. The son had ACC, microcephaly,
bilateral ectrodactyly, low‐lying conus medullaris, horseshoe kidney and tracheoesophageal
fistula. A de novo UBA2 loss-of-function variant [c.1324dupT, p.Tyr442Leufs*17] was
associated with four extremity split hand and foot malformation with tibial deficiency
and under-masculinized external genitalia19. Aerden et al.20 reported a male proband with
ectrodactyly of the feet, autism spectrum disorder, craniofacial variations, dry sparse scalp
hair, strabismus and hypermetropia who was heterozygous for a de novo frameshift variant
in UBA2 [c.612delA, p.Glu205Lysfs*63]; this was considered to be responsible for the
phenotype20.
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The four patients previously reported with intragenic UBA2 variants were added to
our clinical summary table (Table 1) to compare phenotypes18–21. We’ve estimated the
percentage of key traits in UBA2 subjects (Fig. 1c) based on available clinical information.
The most specific aspects of the UBA2-related phenotype are ACC, seen in 61%, and
ectrodactyly, which is less common (37%). Early growth deficiency and neurodevelopmental
delay are reported in 61% and 80% of affected individuals, respectively. More variable
digital and skeletal abnormalities are also present (56%) but are sometimes subtle and
potentially overlooked (e.g., Fig. 1a, panels C, D). These include clinodactyly (62%),
syndactyly (59%), camptodactyly (57%), and hip abnormality (35%).The most common
craniofacial variations are tall forehead/high hairline (76%), down-slanted palpebral fissures
(47%), hypertelorism (62%), broad nasal root (81%), microcephaly (37%), and micrognathia
(53%). Other observed features among our subjects include other ectodermal variations
(~82%), ocular abnormalities (53%), cardiac (43%), genital (50%, in males) and renal (36%)
abnormalities.
In C. elegans, Uba-2 is also noted to be a critical element of the SUMOylation
pathway; its ablation leads to embryonic lethality22. UBA2 acute knockdown in xenograft
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tumors by conditional shRNAs causes marked growth arrest, cell proliferation defects
and increased apoptosis23. In mice, loss of any key component of the SUMOylation
pathway can lead to severe impairment of cellular functions and lethality24,25. An in-situ
hybridization study conducted in mouse embryos (8.5 to 11.5 days post-coitum) revealed
Uba2 ample expression at multiple morphogenetic activity sites, e.g. neural folds, branchial
arches and limb buds24, suggesting that Uba2 is essential for normal cellular function/
development. Recently, SUMOylation was reported to regulate differentiation of several
ocular tissues26,27.

Author Manuscript

Phenotypic features in our human UBA2-related syndrome cohort and the uba2 knockout
zebrafish are reminiscent of disorders associated with pathogenic variants in DLX5/6 (split
hand/foot malformation (SHFM1, OMIM: 220600), TP63 (e.g., Ectrodactyly, ectodermal
dysplasia, and cleft lip/palate syndrome 3, EEC3, OMIM: 604292, split hand/foot
malformation syndrome 4, SHFM4, OMIM: 605289 and others) and FBXW4, a candidate
for SHFM3 (OMIM: 246560). tp63−/− zebrafish embryos have ectodermal defects involving
skin, absent pectoral fin buds and reduced size fin folds at 36hpf and embryos died between
40–50hpf28. tp63 zebrafish morphants affect skin integrity by making the skin more prone
to microbial infection29. fndc3a−/−zebrafish show broken actinotrichia, aberrant collagen
localization and cellular defects in epidermal cells during caudal fin development30. It is
possible that these genes function downstream of the SUMOylation pathway, leading to
phenotypes that overlap the UBA2-related syndrome.
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In the current study, the mRNA rescue experiments showed that WT-UBA2 mRNA injection
partially rescued the abnormal head/eye, tail, and uninflated swim bladder phenotype
in uba2−/− zebrafish (33%). Notably, three of four human missense UBA2 mRNAs did
not rescue the uba2−/−phenotype to a significant degree, suggesting a loss-of-function
mechanism for these disease-associated alleles. As wide phenotypic variability is observed
in both fish and human UBA2/uba2-related phenotypes, additional studies are warranted
to define potential modifiers. Morpholinos (MOs) have been used in reverse genetic
studies in a range of animal models31,32. However, MOs may be hard to interpret as they
typically result in more severe phenotypes33. mRNA rescue in CRISPR-generated stable
mutant lines are potentially useful in the interpretation of MO-related inconsistencies.
Precise single nucleotide variant animal models of human diseases can help to better
understand underlying molecular processes and may aid in management of UBA2-related
abnormalities34.

Author Manuscript

In conclusion, we report clinical details in 16 individuals from seven unrelated families
with inherited or de novo heterozygous UBA2 sequence variants, who present with
highly variable phenotypes. Definition of the UBA2-related autosomal dominant phenotypic
spectrum in humans, in silico modeling predictions, uba2 expression and characterization
of the knock out phenotype in zebrafish support the significance of UBA2/uba2 in
development, potentially by affecting post-translational modification of SHFM-associated
genes. mRNA rescue experiments in zebrafish also suggest that loss of gene function
is the primary mechanism of disease. The highly variable expressivity of the human
UBA2 phenotype, either via sequence alteration or contiguous gene deletion, even within
the same family, remains incompletely explained; there are likely other modifiers, still
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to be identified. However, our studies define a human disorder associated with UBA2
sequence variants with a phenotype that overlaps key aspects of the chromosome 19q13.11
microdeletion syndrome.
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Figure 1: a. Clinical phenotypes and b. Pedigrees associated with UBA2-related syndrome.

a. Family 1, III-2: A. prominent forehead, high hairline, discolored peg-shaped teeth with
gap between upper incisors, cleft chin B. low set ear with simple cartilaginous pattern C.
diminished distal flexion creases D. brachydactyly, mild 2–3 syndactyly, clinodactyly of the
4th toe.
Family 1, IV-4: E. prominent forehead, high hairline, cleft chin, mildly down-slanted
palpebral fissures F. ACC G. repaired ectrodactyly, hypoplastic distal flexion creases H.
ichthyosis
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Family 3, I-1: I. tall forehead, hypertelorism, broad nasal root, mild micrognathia J. ACC
Family 3, II-1: K. tall forehead, hypertelorism, broad nasal root, thin upper lip, medial
eyebrow flare L. ACC
Family 3, II-2: M. facial features N. supernumerary nipple (arrow)
Family 3, III-1: O. tall forehead, low-set ears, micrognathia P. ACC
Family 6, II-1 Q. high forehead, hypertelorism, bilateral epicanthal folds R, S. bilateral 2–3
finger syndactyly, camptodactyly T. bilateral ectrodactyly of the feet
b. Affected individuals are shown as filled symbols. Genotypes are shown below each
individual who was genotyped.
c. Percentages of different clinical features variably expressed in UBA2-affected individuals
based on available data. Previously reported UBA2 patients are also included in the
percentages.
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Figure 2: UBA2 syndrome-associated variants and molecular modeling.
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a. Schematic representation of the UBA2 gene. Exons are shown in brown color boxes;
introns and 3’ and 5’ UTRs are in light grey and purple, respectively. Newly reported UBA2
missense and loss-of-function variants are shown in red and green, respectively, while blue is
used to represent previously reported UBA2 variants. b. Schematic representation of UBA2
protein domains. The UBA2 protein domain carrying catalytically active sites of ubiquitin
activating enzyme is shown in light green. This domain has putative active sites to bind ATP,
substrate, and zinc with the last of five conserved cysteine residues playing an important role
in ubiquitin thioester complex formation. UBA2-C (C-terminus) and UAE-UbL (ubiquitin
like) domains are shown in pink and blue, representing the C-terminus of UBA2 protein.
UAE-UbL is structurally similar to ubiquitin and is involved in E1-SUMO-thioester transfer
to E2 conjugation protein. The amino acid changes for the aforementioned variants are
shown in the same color scheme as Figure 2B. c. Amino acid sequence alignments of the
human UBA2 protein across different species at each of the residues reported with missense
variants. d. Molecular modeling of human UBA2 protein. Secondary structure helix, strand
and coil regions are shown in purple, yellow and cyan blue shades, respectively. Forest green
color is used to show residues of interest in proteins with WT and missense changes and the
ATP molecule is shown in brick red color. Blue color shows regions of hydrogen bonding
and light pink shows residues involved in hydrogen bond formation with residues of interest.
The distances to nearby residues are shown by dashed yellow lines. Last panel: UBA2 and
UBC9 are shown in hot pink and cyan blue color, respectively. As per molecular modeling
predictions, p.Gly24Val: Glycine is flexible enough to maintain torsion angles and is buried
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in the protein core to maintain local secondary structure. p.Asn56Thr. Introducing a smaller
but more hydrophobic residue at Asparagine 56 results in an empty space in the protein core
and subsequent loss of hydrogen bonding with Asp53. p.Arg122Gly: The typical Arginine
122 residue is involved in hydrogen bonding with Asn118, Gly138 and Ser139. Replacement
with Glycine is predicted to disrupt this array.
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Figure 3: Severe dysmorphic features in embryonic uba2−/− zebrafish.
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a-b. Dorsal and lateral views of uba2 zebrafish at 8 dpf. Compared to WT controls,
mutant lines showed aberrant head development with small eyes and hydrocephalus. c. Bar
graph representing the percentage of uba2−/− zebrafish with gross morphological defects.
d. Survival curve showing the number of live fish over the course of 21 days. WT and
heterozygous fish showed similar death curves, but homozygous fish had steeper death
curves with 100% mortality by day 12. PF (pectoral fins), T (tail), B (brain), F (craniofacial)
and SB (swim bladder).
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Figure 4: Cranial cartilage patterns observed in uba2−/− zebrafish and rescue of uba2 mutant
phenotype with human UBA2 mRNA.

a-b. Brightfield ventral and lateral views of cartilage stained uba2 in wild type and
homozygous mutant fish are shown in top and bottom panels, respectively. Closeups of
pectoral fin cartilage phenotype are shown in inserts in the bottom panel highlighted
by black dashed boxes on lateral views. an (anterior), mk (Meckel’s cartilage), pq
(palatoquadrate), ep (ethmoid plate), ch (ceratohyal), h (hypohyal), cb (ceratobranchials
1–4), hs (hyosymplectic). c. Z-stack images of uba2 zebrafish median fins stained with
Col2a (green), Rhodamine-Phalloidin (red) and Dapi (blue). Arrows are used to show the
Genet Med. Author manuscript; available in PMC 2021 November 26.
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gaps between actinotrichia fibers. Scale bar: 50 μm. d. Suppression of uba2 in zebrafish
produces an abnormal phenotype which is classified into three categories. e. Proportions
of uba2−/− zebrafish embryos representing each phenotype category after injecting with
WT or mutation harboring human UBA2 mRNA. Landmark abbreviations: Nor St (normal
structure), Ab (abnormal) and ns (not significant). Chi Square test p-values are shown above
the phenotypes for each rescue experiment.
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Oligodactyly

Author Manuscript

Developmental
delay/
neurodevelopmental
details

none reported

none reported

none reported

none reported

Other skeletal
anomalies

Frequent otitis.
Constipation.

Cryptorchidism.
Astigmatism.
Asthma.

Bicuspid aortic
valve. Astigmatism.
S/p cholecystectomy,
migraines. Low back
pain.

Recurrent urinary
tract infections;
asymmetric renal
sizes with reduced
function of
smaller kidney.
Hypothyroidism, s/p
cholecystectomy.
Inguinal
herniorrhaphy.
History of
pseudotumor cerebri.

Other anomalies/
features:
cardiac, renal,
genital, ocular,
miscellaneous

Other genetic/
chromosomal
results

Author Manuscript

urrent
e or
e at
am
ears)
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Global delay
(gross motor and
speech), nonverbal,
refractory seizures,
infantile spasms,
hyperactivity,
hypotonia.

Normal development

Gross, fine motor
and speech delays,
persistent.

Delayed motor
development, normal
cognitive ability.

5

9

5
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75

25–50

75–90

10–25

~75

<3

Delayed motor
skills, attention
deficit disorder, sat
independently at 12
months, walked at 22
months, first word at
18 months, sentences
after 2 years.

Author Manuscript

3rd

~75

10–25

~10

<3

Weight
percentile
(most
recent or
at stated
age)

25–50

25

5–10

~25

<3

Head
circumference
percentile
(most recent /
stated age)

yes

no

no

no

yes

Early
growth
problems

Tall forehead/
high hairline,
downslanted
palpebral
fissures,
suspected
hypertelorism
and broad nasal
root

Tall forehead/
high hairline,
broad nasal root,
left preauricular
ear tag, narrow
palate, vertical
cleft/groove in
chin

Tall forehead/
high hairline,
hypertelorism,
epicanthal folds,
pseudostrabismus

Epicanthal folds

High hairline,
broad forehead,
hypertelorism,
broad nasal root,
delayed
dentition, mild
facial
dysmorphism

Craniofacial
features

Author Manuscript

Height
percentile
(most
recent or
at stated
age)

yes,
single
large area

no

no

yes

yes

Aplasia
cutis
congenita

Thin hair in
photos.

Diffuse patches of
hypopigmentation.

Normal hair and
nails.

Thin, sparse hair,
coarse skin, poor
sweating, cries
with tears.

Other
ectodermal
variations

no

4 limb
ectrodactyly,
oligodactyly
of both feet

yes, bilateral
ectrodactyly
of the feet

no

Ectrodactyly/
Oligodactyly

Author Manuscript

Developmental
delay/
neurodevelopmental
details

Clinodactyly, hip
abnormality

Syndactyly as
part of
ectrodactyly

Clinodactyly,
complete bilateral
2–3 finger
syndactyly
camptodactyly

Pes planus

Clinodactyly,
overlapping toes
on right foot
(3,4), delayed
bone age,
kyphoscoliosis
treated with
bracing

Other skeletal
anomalies

Duane anomaly,
strabismus.
Recurrent otitis
media, croup,
tonsillitis.

VSD, not clinically
significant

Cryptorchidism.
Bilateral inguinal
hernias.

Hemangiomas (left
ear, back).
Anteriorly placed
anus.

Renal hypoplasia,
chronic kidney
disease, stable.
Bilateral optic nerve
hypoplasia with
normal vision.
Postural orthostatic
hypotension.
Hypothyroidism,
growth hormone
treatment,
headaches, no
breast development
(budding only),
menarche at 14
years, pubic hair, no
axillary hair.

Other anomalies/
features:
cardiac, renal,
genital, ocular,
miscellaneous

Normal prenatal
microarray; normal
WES at another
clinical lab

Normal SNP
microarray

Normal microarray,
normal Prader
Willi/Angelman
methylation, epilepsy
panel: heterozygous
VUS in GABRB3,
paternal: p.R409Q

BAZ1B:heterozygous
VUS, de novo
fs c.3317delA;
SOS1: heterozygous
variant c.281T>C;
COX1: homoplasmic
p.I97V; NRXN1:
heterozygous VUS,
p.G744R (maternal)

Other genetic/
chromosomal
results

Author Manuscript

urrent
e or
e at
am
ears)
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Speech delay, normal
motor milestones,
learning difficulties,
autism diagnosed at
8 years, intelligence
quotient 76.

Normal development

~25–50
(3.6
years)

10–25
(birth)

Normal development

Author Manuscript

~25 (3.6
years)

<3 (birth)

Weight
percentile
(most
recent or
at stated
age)

~20 (3.6 years)

<10 (birth)

Head
circumference
percentile
(most recent /
stated age)

yes

Early
growth
problems

Retrognathia,
low set and
prominent ears,
fullness of upper
eyelids.

Craniofacial
features

Author Manuscript

Height
percentile
(most
recent or
at stated
age)

yes

Yes, two
areas

Aplasia
cutis
congenita

Supernumerary
nipple, increased
hair on back, dry,
sparse scalp hair.

Other
ectodermal
variations

yes

no

Polydactyly with
six metatarsals on
right foot,
multiple bony
anomalies in feet,
syndactyly of
toes, normal
hands, transient
hip instability.
Normal hands.

none reported

Syndactyly as
part of
ectrodactyly, low
lying conus
medullaris

Clinodactyly, long
bone deficiency
of tibias

Bilateral
ectrodactyly,
oligodactyly,
hands and
feet
Bilateral
ectrodactyly,
oligodactyly

Other skeletal
anomalies

Ectrodactyly/
Oligodactyly

Author Manuscript

Developmental
delay/
neurodevelopmental
details

Strabismus,
hypermetropia

Horseshoe kidney,
tracheo-esophageal
fistula

Undermasculinized
external genitalia

Other anomalies/
features:
cardiac, renal,
genital, ocular,
miscellaneous

Normal karyotype,
microarray

Other genetic/
chromosomal
results

Author Manuscript

urrent
e or
e at
am
ears)
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